Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$5.36 - $7.43 $23.4 Million - $32.4 Million
-4,361,545 Reduced 54.2%
3,685,683 $21.5 Million
Q2 2022

Aug 15, 2022

BUY
$3.55 - $6.27 $3.22 Million - $5.69 Million
906,778 Added 12.7%
8,047,228 $48 Million
Q1 2020

May 06, 2020

BUY
$0.69 - $1.54 $2.34 Million - $5.22 Million
3,390,450 Added 90.41%
7,140,450 $6.57 Million
Q1 2018

May 10, 2018

BUY
$2.7 - $4.06 $10.1 Million - $15.2 Million
3,750,000 New
3,750,000 $14.6 Million

About CTI BIOPHARMA CORP


  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Nea Management Company, LLC Portfolio

Follow Nea Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nea Management Company, LLC with notifications on news.